Offerings // ANI PHARMACEUTICALS INC

ANIP offering history

Every offering-related filing in ANI PHARMACEUTICALS INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to May 29, 2014.

Last executed offering

Sep 26, 2025

8-K — priced deal (shares or notes)

Last registration (announced)

Dec 17, 2021

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 26, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 13, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 12, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 11, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 19, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 18, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 17, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 26, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 5, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 3, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 9, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 17, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 9, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 11, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 12, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 23, 2015	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 8, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 5, 2014	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 4, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 13, 2014	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 30, 2014	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet

ANIP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ANIP workspace →

ANIP offering FAQ

When did ANIP last execute an offering?

Per SEC filings, ANI PHARMACEUTICALS INC's most recent priced offering document is a 8-K filed 2025-09-26. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ANIP last announce or register an offering?

The most recent registration is a S-3 filed 2021-12-17. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.